How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades. We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.

NEPH Insider Trading (Nephros)

Insider Ownership Percentage: 8.60%
Insider Buying (Last 12 Months): $65,295.00
Insider Selling (Last 12 Months): $0.00

Nephros Insider Trading History Chart

This chart shows the insider buying and selling history at Nephros by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Nephros Share Price & Price History

Current Price: $1.79
Price Change: Price Decrease of -0.07 (-3.76%)
As of 05/20/2022 01:00 AM ET

This chart shows the closing price history over time for NEPH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades. We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.

Nephros Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/20/2021Wesley S. LoboCMOBuy1,000$7.92$7,920.00View SEC Filing Icon  
8/18/2021Tom GwydirDirectorBuy5,000$7.64$38,200.0011,031View SEC Filing Icon  
8/17/2021Andrew AstorCEOBuy2,500$7.67$19,175.0075,458View SEC Filing Icon  
11/19/2020Andrew AstorCEOBuy1,000$5.87$5,870.0072,958View SEC Filing Icon  
8/19/2020Andrew AstorCFOBuy950$7.40$7,030.0071,958View SEC Filing Icon  
5/28/2020Andrew AstorCFOBuy1,000$7.80$7,800.00
3/5/2020Daron EvansCEOBuy2,500$8.25$20,625.00
11/25/2019Oliver J SpandowDirectorBuy1,000$8.42$8,420.00
11/18/2019Daron EvansCEOBuy1,000$8.30$8,300.00
8/22/2019Andrew AstorCFOBuy1,500$6.97$10,455.00View SEC Filing Icon  
8/22/2019Daron EvansInsiderBuy2,000$6.92$13,840.00View SEC Filing Icon  
6/14/2019Andrew AstorCFOBuy35,000$0.64$22,400.00View SEC Filing Icon  
6/14/2019Daron EvansInsiderBuy43,172$0.60$25,903.20View SEC Filing Icon  
See Full Table
Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.

SEC Filings (Institutional Ownership Changes) for Nephros (NASDAQ:NEPH)

55.55% of Nephros stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NEPH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Nephros Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/13/2022Wexford Capital LP3,663,969$533.73M26.0%+0.4%35.507%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC20,317$89K0.0%N/A0.197%Search for SEC Filing on Google Icon
5/11/2022Bard Associates Inc.246,408$1.08M0.4%+6.0%2.388%Search for SEC Filing on Google Icon
5/10/2022Elkhorn Partners Limited Partnership23,712$0.10M0.1%+56.0%0.230%Search for SEC Filing on Google Icon
5/4/2022Advisor Group Holdings Inc.8,674$38K0.0%+89.6%0.084%Search for SEC Filing on Google Icon
5/2/2022Cowen Prime Advisors LLC80,400$0.35M0.1%-87.3%0.780%Search for SEC Filing on Google Icon
2/19/2022Wexford Capital LP3,650,529$646.53M27.0%N/A35.674%Search for SEC Filing on Google Icon
2/14/2022Elkhorn Partners Limited Partnership15,200$90K0.1%+78.8%0.149%Search for SEC Filing on Google Icon
2/8/2022Cowen Prime Advisors LLC633,050$3.74M1.3%-4.1%6.186%Search for SEC Filing on Google Icon
2/8/2022Samjo Capital LLC425,000$2.51M1.7%-22.7%4.153%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC13,424$0.12M0.0%-10.6%0.131%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley13,837$0.12M0.0%+186.3%0.135%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.18,079$0.16M0.0%-23.0%0.177%Search for SEC Filing on Google Icon
11/2/2021Cowen Prime Advisors LLC660,150$5.79M2.2%+5.4%6.461%Search for SEC Filing on Google Icon
8/17/2021Wexford Capital LP3,631,197$36.85M5.6%+1.9%35.541%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC15,023$0.16M0.0%-20.6%0.147%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.99,936$1.01M0.0%+3.9%0.978%Search for SEC Filing on Google Icon
8/12/2021Bard Associates Inc.231,508$2.35M0.8%+5.5%2.266%Search for SEC Filing on Google Icon
8/4/2021Cowen Prime Advisors LLC626,450$6.36M2.3%N/A6.290%Search for SEC Filing on Google Icon
8/2/2021Advisor Group Holdings Inc.4,574$46K0.0%+91,380.0%0.046%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC18,421$0.12M0.0%N/A0.185%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC18,909$0.13M0.0%-10.4%0.190%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC18,421$0.12M0.0%N/A0.185%Search for SEC Filing on Google Icon
5/13/2021Wexford Capital LP3,564,530$23.70M3.5%+0.1%35.781%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.23,559$0.16M0.0%+20.9%0.237%Search for SEC Filing on Google Icon
4/27/2021Cowen Prime Services LLC622,750$4.14M1.6%+8.3%6.258%Search for SEC Filing on Google Icon
2/12/2021Elkhorn Partners Limited Partnership14,290$0.12M0.1%-9.0%0.145%Search for SEC Filing on Google Icon
2/11/2021Samjo Capital LLC550,000$4.72M4.0%N/A5.575%Search for SEC Filing on Google Icon
2/10/2021HighTower Advisors LLC55,710$0.48M0.0%+28.9%0.565%Search for SEC Filing on Google Icon
1/27/2021Cowen Prime Services LLC575,077$4.93M2.2%+86.1%5.829%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.18,333$0.13M0.0%-28.1%0.203%Search for SEC Filing on Google Icon
10/29/2020Cowen Prime Services LLC309,009$2.23M1.1%+22.6%3.418%Search for SEC Filing on Google Icon
8/12/2020Blair William & Co. IL36,249$0.30M0.0%+5.8%0.401%Search for SEC Filing on Google Icon
7/29/2020Cowen Prime Services LLC251,994$2.11M1.0%+62.8%2.798%Search for SEC Filing on Google Icon
5/18/2020Wexford Capital LP3,395,579$21.39M7.9%N/A37.699%Search for SEC Filing on Google Icon
5/4/2020Essex Investment Management Co. LLC39,863$0.25M0.1%N/A0.443%Search for SEC Filing on Google Icon
5/1/2020BlackRock Inc.8,659$54K0.0%+238.0%0.096%Search for SEC Filing on Google Icon
4/28/2020Cowen Prime Services LLC154,800$0.98M0.6%N/A1.719%Search for SEC Filing on Google Icon
4/22/2020Ingalls & Snyder LLC133,140$0.84M0.1%-1.0%1.478%Search for SEC Filing on Google Icon
2/13/2020Parkman Healthcare Partners LLC199,724$1.99M0.6%N/A2.478%Search for SEC Filing on Google Icon
2/10/2020National Asset Management Inc.14,254$0.14M0.0%-45.5%0.177%Search for SEC Filing on Google Icon
1/15/2020Ingalls & Snyder LLC134,539$1.34M0.1%+104.5%1.690%Search for SEC Filing on Google Icon
11/27/2019Millennium Management LLC38,521$0.31M0.0%N/A0.484%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Nephros logo
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Read More on Nephros

Today's Range

Now: $1.79
Low: $1.74
High: $1.87

50 Day Range

MA: $3.80
Low: $1.79
High: $4.89

52 Week Range

Now: $1.79
Low: $1.74
High: $11.67

Volume

22,009 shs

Average Volume

113,106 shs

Market Capitalization

$18.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.23

Who are the company insiders with the largest holdings of Nephros?

Nephros' top insider shareholders include:
  1. Andrew Astor (CEO)
  2. Andrew Astor (CFO)
  3. Tom Gwydir (Director)
  4. Wesley S Lobo (CMO)
Learn More about top insider investors at Nephros.

Who are the major institutional investors of Nephros?

Nephros' top institutional investors include:
  1. Wexford Capital LP — 35.51%
  2. Bard Associates Inc. — 2.39%
  3. Cowen Prime Advisors LLC — 0.78%
  4. Elkhorn Partners Limited Partnership — 0.23%
  5. Renaissance Technologies LLC — 0.20%
  6. Advisor Group Holdings Inc. — 0.08%
Learn More about top institutional investors of Nephros stock.

Which major investors are selling Nephros stock?

In the last quarter, NEPH stock was sold by these institutional investors:
  1. Cowen Prime Advisors LLC

Which major investors are buying Nephros stock?

Within the last quarter, NEPH stock was purchased by institutional investors including:
  1. Renaissance Technologies LLC
  2. Bard Associates Inc.
  3. Wexford Capital LP
  4. Elkhorn Partners Limited Partnership
  5. Advisor Group Holdings Inc.
During the last year, these company insiders have bought Nephros stock:
  1. Andrew Astor (CEO)
  2. Andrew Astor (CFO)
  3. Tom Gwydir (Director)
  4. Wesley S Lobo (CMO)
Learn More investors buying Nephros stock.
Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.